Kestra Medical GC awarded 58,832 common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. reported that director and General Counsel Traci S. Umberger acquired 58,832 Common Shares on July 15, 2026 at $0.00 per share, reflecting the vesting of performance-based RSUs (PSUs) granted on July 17, 2025. After this award, Umberger directly holds 221,634 Common Shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares F1 | 58,832 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.
Key Figures
Key Terms
performance-based RSUs financial
PSUs financial
vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did KMTS report for Traci S. Umberger?
When were the KMTS performance-based RSUs granted and when did they vest?
Was the reported KMTS insider transaction under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.